Roflumilast

An orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3',5'-adenosine monophosphate (cAMP) and cAMP-mediated signaling. cAMP prevents phosphorylation of spleen tyrosine kinase (SYK) and abrogates activation of the PI3K/AKT/mTOR signaling pathway, which may result in the induction of apoptosis. PDE4, a member of the PDE superfamily that hydrolyses cAMP and 3',5'-cyclic guanosine monophosphate (cGMP) to their inactive 5' monophosphates, is upregulated in a variety of cancers and may contribute to chemoresistance; it also plays a key role in inflammation, especially in inflammatory airway diseases. (NCI Thesaurus)

YOU MAY ALSO LIKE

Rofecoxib

A drug that was being used for pain relief and was being studied for its ability to prevent cancer and to prevent…

Roentgen

A unit of exposure to ionizing radiation in CGS system. One roentgen is the amount of gamma or x-rays required to produce…

Rodorubicin

A synthetic tetraglycosidic anthracycline antibiotic with antineoplastic activity. Rodorubicin appears to intercalate DNA and causes cell death. Due to its severe cardiotoxic…

Rodentia

The taxonomic order of mammals that includes mice, rats, guinea pigs, squirrels, beavers, and many others.

Rodent Nomenclature Name

Official nomenclature name for mouse and rat models.

Rodent Model of Disease

A rodent disease whose pathologic mechanisms are sufficiently similar to those of a human disease to serve as a model.